A pilot randomized trial of nebulized amphotericin in patients with allergic bronchopulmonary aspergillosis
Babu Ram(Post Graduate Institute of Medical Education and Research), Ritesh Agarwal(Albert Einstein College of Medicine), Arunaloke Chakrabarti(Dev Sanskriti Vishwavidyalaya), Sahajal Dhooria(Post Graduate Institute of Medical Education and Research), Inderpaul Singh Sehgal(Post Graduate Institute of Medical Education and Research), Ashutosh N. Aggarwal(All India Institute of Medical Sciences Raipur), Digambar Behera(Post Graduate Institute of Medical Education and Research), Mandeep Garg(Post Graduate Institute of Medical Education and Research)
Cited by 69
Related Papers
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k
Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria
|Clinical & Experimental Allergy|2013|895
Health and economic impact of air pollution in the states of India: the Global Burden of Disease Study 2019
|The Lancet Planetary Health|2020|707